Concept paper on good genomics biomarker practices

Posted on Updated on

Document details

http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2014/08/WC500170682.pdf

Download document Concept paper on good genomics biomarker practices
Reference number EMA/CHMP/PGWP/415990/2014
Status draft: consultation open
First published 04/08/2014
Last updated 04/08/2014
Consultation start date 04/08/2014
Consultation end date 04/11/2014
Email address for submissions pgwpsecretariat@ema.europa.eu

Summary

Genomic data have become important to evaluate efficacy and safety of a drug for regulatory approval. As a result, genomic information has been increasingly included in drug labels relevant for the benefit/risk evaluation of a drug and consequently as guidance for patient treatment.

 

 

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s